These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10449291)

  • 21. [To evaluate the changes in body composition in male human immunodeficiency virus-related lipodystrophy after different treatment regimens by dual-energy X-ray absorptiometry].
    Zhou X; Yu W; Li T; Guo F; Lin Q; Shao H; Tian J; Xu Y; Sun P
    Zhonghua Nei Ke Za Zhi; 2014 Aug; 53(8):622-5. PubMed ID: 25376824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of hypersensitivity to glucocorticoids in antiretroviral-associated lipodystrophy.
    Martin IP; Breen PA; Weigle DS
    Obes Res; 2003 Jan; 11(1):21-4. PubMed ID: 12529481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.
    Gan SK; Samaras K; Thompson CH; Kraegen EW; Carr A; Cooper DA; Chisholm DJ
    Diabetes; 2002 Nov; 51(11):3163-9. PubMed ID: 12401706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pilot study of DXA assessment in chinese HIV-infected men with clinical lipodystrophy.
    Yao J; Yu W; Li T; Luo L; Lin Q; Tian J; Chang Y
    J Clin Densitom; 2011; 14(1):58-62. PubMed ID: 21130671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz.
    Viganò A; Brambilla P; Cafarelli L; Giacomet V; Borgonovo S; Zamproni I; Zuccotti G; Mora S
    Antivir Ther; 2007; 12(3):297-302. PubMed ID: 17591019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal study of body composition of 101 HIV men with lipodystrophy: dual-energy X-ray criteria for lipodystrophy evolution.
    Degris E; Delpierre C; Sommet A; Sire S; Lassoued S; Aquilina C; Marchou B; Massip P; Obadia M; Marion-Latard F; Bonnet E; Bernard J
    J Clin Densitom; 2010; 13(2):237-44. PubMed ID: 20347366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hospital-based exercise program to improve body composition, strength, and abdominal adiposity in 2 HIV-infected children.
    Miller TL
    AIDS Read; 2007 Sep; 17(9):450-2, 455, 458. PubMed ID: 17902228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fat redistribution syndrome in patients infected with HIV: measurements of body shape abnormalities.
    Gerrior J; Kantaros J; Coakley E; Albrecht M; Wanke C
    J Am Diet Assoc; 2001 Oct; 101(10):1175-80. PubMed ID: 11678488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of aerobic or combined aerobic resistance exercise on body composition in overweight and obese adults: gender differences. A randomized intervention study.
    Sanal E; Ardic F; Kirac S
    Eur J Phys Rehabil Med; 2013 Feb; 49(1):1-11. PubMed ID: 22569489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional fat changes induced by localized muscle endurance resistance training.
    Ramírez-Campillo R; Andrade DC; Campos-Jara C; Henríquez-Olguín C; Alvarez-Lepín C; Izquierdo M
    J Strength Cond Res; 2013 Aug; 27(8):2219-24. PubMed ID: 23222084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness of the abdominal CT in diagnosis of the viscero-abdominal fat accumulation in HIV patients treated with protease inhibitors].
    Pedreira JD; Pombo F; Juega J; López-Calvo S; Castro MA
    An Med Interna; 2001 Aug; 18(8):452-3. PubMed ID: 11589092
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipodystrophy in HIV/AIDS: a comparison between physically active, and inactive HIV-infected vs. uninfected men.
    DE Matos CV; Farinatti P; Lopes KG; Borges JP
    J Sports Med Phys Fitness; 2024 Nov; 64(11):1217-1223. PubMed ID: 39101407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy.
    Martínez E; García-Viejo MA; Blanco JL; Bianchi L; Buira E; Conget I; Casamitjana R; Mallolas J; Gatell JM
    Clin Infect Dis; 2000 Nov; 31(5):1266-73. PubMed ID: 11073762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of switching from lopinavir/ritonavir to atazanavir/ritonavir on body fat redistribution in virologically suppressed HIV-infected adults.
    Ferrer E; del Rio L; Martínez E; Curto J; Domingo P; Ribera E; Negredo E; Rosales J; Saumoy M; Ordóñez J; Gatell JM; Podzamczer D
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1061-5. PubMed ID: 21166602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of lipodystrophy (LD) with continued thymidine analogue usage: long-term follow-up from a randomized clinical trial (the PIILR study).
    Martin A; Smith D; Carr A; Hoy J; Chuah J; Mallal S; Law M; Clements M; Cooper DA;
    HIV Clin Trials; 2004; 5(4):192-200. PubMed ID: 15472793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.
    Carr A; Workman C; Smith DE; Hoy J; Hudson J; Doong N; Martin A; Amin J; Freund J; Law M; Cooper DA;
    JAMA; 2002 Jul; 288(2):207-15. PubMed ID: 12095385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways.
    van der Valk M; Bisschop PH; Romijn JA; Ackermans MT; Lange JM; Endert E; Reiss P; Sauerwein HP
    AIDS; 2001 Nov; 15(16):2093-100. PubMed ID: 11684928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy.
    Yarasheski KE; Tebas P; Stanerson B; Claxton S; Marin D; Bae K; Kennedy M; Tantisiriwat W; Powderly WG
    J Appl Physiol (1985); 2001 Jan; 90(1):133-8. PubMed ID: 11133903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.
    Carr A; Samaras K; Thorisdottir A; Kaufmann GR; Chisholm DJ; Cooper DA
    Lancet; 1999 Jun; 353(9170):2093-9. PubMed ID: 10382692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fat redistribution in indinavir-treated patients with HIV infection: A review of postmarketing cases.
    Benson JO; McGhee K; Coplan P; Grunfeld C; Robertson M; Brodovicz KG; Slater E
    J Acquir Immune Defic Syndr; 2000 Oct; 25(2):130-9. PubMed ID: 11103043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.